ZYXI - Zynex reaffims FY23 EPS $0.40-$0.50 vs. consensus $0.45

2023-07-12 10:24:31 ET

• Zynex ( NASDAQ: ZYXI ) reiterates its full year 2023 guidance of revenue between $180 - $200M vs. consensus of $192.68M and EPS between $0.40 - $0.50 vs. consensus of $0.45.
• The Co. continues to see strong growth in its pain management division across device and supply sales.
• Q2 orders increased 51% over the same period in 2022, providing further proof of our ability to deliver consistently strong profitable growth as we expand sales territories.
• Also, confirms its previous estimates for Q2 revenue of $43.5 - $45.5M vs. consensus of $44.6M and earnings per share between $0.03 - $0.07 vs. consensus of $0.05 .
• "Our Q2 revenue estimate is an increase of ~21% over the prior year period, and I am pleased with our continued strong momentum, solid order growth, and continued productivity in our sales force." said Thomas Sandgaard, CEO.

For further details see: